Search

Noble E. Jarrell

Examiner (ID: 14167, Phone: (571)272-9077 , Office: P/1625 )

Most Active Art Unit
1699
Art Unit(s)
1625, 1699, 1622, 1624, 1609
Total Applications
1419
Issued Applications
950
Pending Applications
180
Abandoned Applications
334

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 17713465 [patent_doc_number] => 11377448 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-07-05 [patent_title] => Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid [patent_app_type] => utility [patent_app_number] => 16/499732 [patent_app_country] => US [patent_app_date] => 2018-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 4397 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499732 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/499732
Crystalline sodium salt of 5-methyl-(6S)-tetrahydrofolic acid Mar 27, 2018 Issued
Array ( [id] => 15948745 [patent_doc_number] => 10662261 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-05-26 [patent_title] => Chelator and use thereof [patent_app_type] => utility [patent_app_number] => 15/937428 [patent_app_country] => US [patent_app_date] => 2018-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9493 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15937428 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/937428
Chelator and use thereof Mar 26, 2018 Issued
Array ( [id] => 17089715 [patent_doc_number] => 11117892 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-09-14 [patent_title] => Pyrrolo-pyridine derivative compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of protein kinase-related diseases [patent_app_type] => utility [patent_app_number] => 16/495455 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 24102 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 504 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495455 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/495455
Pyrrolo-pyridine derivative compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of protein kinase-related diseases Mar 22, 2018 Issued
Array ( [id] => 17921633 [patent_doc_number] => 11464854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-10-11 [patent_title] => Methods and compositions relating to adjuvants [patent_app_type] => utility [patent_app_number] => 16/495901 [patent_app_country] => US [patent_app_date] => 2018-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 88 [patent_figures_cnt] => 90 [patent_no_of_words] => 41992 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16495901 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/495901
Methods and compositions relating to adjuvants Mar 22, 2018 Issued
Array ( [id] => 16735600 [patent_doc_number] => 10961235 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-30 [patent_title] => Crystalline form of masitinib [patent_app_type] => utility [patent_app_number] => 16/498483 [patent_app_country] => US [patent_app_date] => 2018-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 10491 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498483 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/498483
Crystalline form of masitinib Mar 21, 2018 Issued
Array ( [id] => 15800063 [patent_doc_number] => 20200123174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-23 [patent_title] => NOVEL PTEFB INHIBITING MACROCYCLIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/498662 [patent_app_country] => US [patent_app_date] => 2018-03-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40504 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16498662 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/498662
PTEFb inhibiting macrocyclic compounds Mar 21, 2018 Issued
Array ( [id] => 15708651 [patent_doc_number] => 20200101091 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-02 [patent_title] => ACYLNUCLEOSIDE PHOSPHONATES, PRODRUGS THEREOF AND USE THEREOF AS MEDICAMENT [patent_app_type] => utility [patent_app_number] => 16/496888 [patent_app_country] => US [patent_app_date] => 2018-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15432 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 449 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16496888 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/496888
Acylnucleoside phosphonates, prodrugs thereof and use thereof as medicament Mar 20, 2018 Issued
Array ( [id] => 13314605 [patent_doc_number] => 20180208839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => COLOR CONVERSION FILMS COMPRISING A RHODAMINE-BASED FLUORESCENT (RBF) COMPOUND AND PLASMON ENHANCED FLUORESCENT DYES [patent_app_type] => utility [patent_app_number] => 15/924302 [patent_app_country] => US [patent_app_date] => 2018-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18840 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 288 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15924302 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/924302
COLOR CONVERSION FILMS COMPRISING A RHODAMINE-BASED FLUORESCENT (RBF) COMPOUND AND PLASMON ENHANCED FLUORESCENT DYES Mar 18, 2018 Abandoned
Array ( [id] => 13335247 [patent_doc_number] => 20180219161 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-02 [patent_title] => Tetradentate Platinum (II) Complexes Cyclometalated With Functionalized Phenyl Carbene Ligands And Their Analogues [patent_app_type] => utility [patent_app_number] => 15/925084 [patent_app_country] => US [patent_app_date] => 2018-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15925084 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/925084
Tetradentate platinum (II) complexes cyclometalated with functionalized phenyl carbene ligands and their analogues Mar 18, 2018 Issued
Array ( [id] => 16376290 [patent_doc_number] => 20200325132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-15 [patent_title] => TRICYCLIC COMPOUNDS FOR USE IN TREATMENT OF PROLIFERATIVE DISORDERS [patent_app_type] => utility [patent_app_number] => 16/494570 [patent_app_country] => US [patent_app_date] => 2018-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26321 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494570 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494570
Tricyclic compounds for use in treatment of proliferative disorders Mar 15, 2018 Issued
Array ( [id] => 17968217 [patent_doc_number] => 11485731 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-01 [patent_title] => Compounds and methods useful in the treatment of a PRMT5-mediated disorder [patent_app_type] => utility [patent_app_number] => 16/494532 [patent_app_country] => US [patent_app_date] => 2018-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31675 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 532 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16494532 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/494532
Compounds and methods useful in the treatment of a PRMT5-mediated disorder Mar 15, 2018 Issued
Array ( [id] => 15363379 [patent_doc_number] => 20200017454 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => MACROCYCLIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 16/491379 [patent_app_country] => US [patent_app_date] => 2018-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50063 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -56 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16491379 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/491379
Macrocyclic compounds Mar 14, 2018 Issued
Array ( [id] => 18543668 [patent_doc_number] => 11716992 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-08-08 [patent_title] => 5A5B6C tricyclic spirolactone derivative, preparation method therefor and use thereof [patent_app_type] => utility [patent_app_number] => 16/755162 [patent_app_country] => US [patent_app_date] => 2018-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19311 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16755162 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/755162
5A5B6C tricyclic spirolactone derivative, preparation method therefor and use thereof Mar 13, 2018 Issued
Array ( [id] => 15405333 [patent_doc_number] => 20200022988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-23 [patent_title] => Fused Pentacyclic Imidazole Derivatives as Modulators of TNF Activity [patent_app_type] => utility [patent_app_number] => 16/487988 [patent_app_country] => US [patent_app_date] => 2018-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30523 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16487988 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/487988
Fused pentacyclic imidazole derivatives as modulators of TNF activity Mar 13, 2018 Issued
Array ( [id] => 17307321 [patent_doc_number] => 11208413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-28 [patent_title] => Pyrimidopyrimidinones useful as wee-1 kinase inhibitors [patent_app_type] => utility [patent_app_number] => 16/492292 [patent_app_country] => US [patent_app_date] => 2018-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6882 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16492292 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/492292
Pyrimidopyrimidinones useful as wee-1 kinase inhibitors Mar 11, 2018 Issued
Array ( [id] => 17267479 [patent_doc_number] => 11192890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-12-07 [patent_title] => FGFR kinase inhibitors and pharmaceutical uses [patent_app_type] => utility [patent_app_number] => 16/490717 [patent_app_country] => US [patent_app_date] => 2018-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 22 [patent_no_of_words] => 28682 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16490717 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/490717
FGFR kinase inhibitors and pharmaceutical uses Mar 1, 2018 Issued
Array ( [id] => 15102131 [patent_doc_number] => 10472365 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-12 [patent_title] => Short-acting benzodiazepine salts and their polymorphic forms [patent_app_type] => utility [patent_app_number] => 15/908081 [patent_app_country] => US [patent_app_date] => 2018-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 68 [patent_no_of_words] => 16460 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15908081 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/908081
Short-acting benzodiazepine salts and their polymorphic forms Feb 27, 2018 Issued
Array ( [id] => 15068567 [patent_doc_number] => 10463749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-11-05 [patent_title] => Maytansinoid derivatives, conjugates thereof, and methods of use [patent_app_type] => utility [patent_app_number] => 15/907142 [patent_app_country] => US [patent_app_date] => 2018-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 33430 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15907142 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/907142
Maytansinoid derivatives, conjugates thereof, and methods of use Feb 26, 2018 Issued
Array ( [id] => 16351879 [patent_doc_number] => 10792372 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-06 [patent_title] => Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof [patent_app_type] => utility [patent_app_number] => 15/906416 [patent_app_country] => US [patent_app_date] => 2018-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 36 [patent_no_of_words] => 39259 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15906416 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/906416
Maytansinoid derivatives with self-immolative peptide linkers and conjugates thereof Feb 26, 2018 Issued
Array ( [id] => 13563901 [patent_doc_number] => 20180333498 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-22 [patent_title] => Phospholipid Ether Analogs as Cancer-Targeting Drug Vehicles [patent_app_type] => utility [patent_app_number] => 15/894430 [patent_app_country] => US [patent_app_date] => 2018-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15894430 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/894430
Phospholipid ether analogs as cancer-targeting drug vehicles Feb 11, 2018 Issued
Menu